Xencor (XNCR) Earnings Date & Reports

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XNCR is expected to report earnings to rise 9.08% to -71 cents per share on July 30

Q2'25

Est.

$-0.72

Q1'25

Missed

by $0.04

Q4'24

Beat

by $0.19

Q3'24

Beat

by $0.27

Q2'24

Missed

by $0.25

The last earnings report on May 07 showed earnings per share of -66 cents, missing the estimate of -62 cents. With 561.91K shares outstanding, the current market capitalization sits at 649.08M.

View a ticker or compare two or three

Compare

XNCR